Delivery Order SPE2DB22D3019-SPE2DB25FK3PG
Award Date 5/2/25
Potential Completion Date 5/5/25
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,968.01 to AmerisourceBergen Drug Corp for 60-count tablets of Xifaxan 550 mg, an antibiotic medication used to treat traveler's diarrhea and certain gastrointestinal conditions. This competitively awarded, firm fixed-price delivery order was issued on September 3, 2025, with an ultimate completion date of September 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $36,970.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60-tablet supplies of Xifaxan 550 mg, an antibiotic medication used to treat traveler's diarrhea and irritable bowel syndrome. The contract was competitively awarded without set-aside designation and is scheduled for completion by July 21, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $11,106.33 to AmerisourceBergen Drug Corp for 60-count tablets of Xifaxan 550 mg, an antibiotic used to treat traveler's diarrhea and certain gastrointestinal conditions. This firm fixed price contract, awarded on August 18, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,344.55 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on June 4, 2025, with a completion date of June 5, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999.9...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,419.46 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count) on August 20, 2025, with completion expected by August 21, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a competitive procurement action under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $5,383.18 delivery order to AmerisourceBergen Drug Corp for 60-count tablets of Xifaxan 550 mg, an antibiotic medication commonly used to treat traveler's diarrhea and hepatic encephalopathy. The contract employs firm fixed pricing with a delivery deadline of September 16, 2025, and was awarded on a competitive basis without any set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,249.80 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $61,645.25 to AmerisourceBergen Drug Corp for 60-count bottles of Xifaxan 550 mg tablets, with a firm fixed price and ultimate completion date of September 15, 2025. This non-set-aside, competitively awarded contract is a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement running through December 2026 that enables the...
- The Defense Logistics Agency awarded a delivery order valued at $12,991.41 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) on August 20, 2025, with completion scheduled for August 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- The Defense Logistics Agency awarded a delivery order valued at $18,007.34 to AmerisourceBergen Drug Corp for the supply of Xifaxan 550 mg tablets (60-count units) under a firm fixed price contract. This non-competitive delivery order, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a routine pharmaceutical procurement executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, a major...